Rare diseases
Investigational molecules
Locations
Back to Germany20 clinical trials in Merzig, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
GermanyLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
GermanyA study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
GermanyA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
GermanyStudy on the Safety and Immune Response of Shingrix Vaccine in Patients with Psoriasis or Psoriatic Arthritis
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis
GermanyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa
GermanyStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Multiple groundbreaking studies focusing on Hidradenitis Suppurativa (HS), evaluating novel therapeutic approaches including spesolimab and povorcitinib for moderate to severe cases. These trials aim to establish long-term safety profiles and treatment efficacy for patients who haven't responded to conventional therapies.
Comprehensive research focusing on both adult and adolescent populations.
Important clinical research addressing various skin conditions, including actinic keratosis and plaque psoriasis. Studies are evaluating new topical treatments and comparing their effectiveness with existing therapies.
Focus on innovative approaches for treating chronic skin conditions.
Clinical investigations examining the efficacy of methylprednisolone aceponate formulations for mild to moderate atopic dermatitis. These studies compare different ointment preparations to optimize treatment outcomes.
Research aimed at improving therapeutic options for atopic dermatitis patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
